Harvard researchers warn that drug companies spend billions of dollars advertising medications which are not as effective, and often more expensive, than other options, researchers warn.
A new study reveals the potential extent to which the medical device and pharmaceutical industries are influencing important health care decisions and how they can conflict with patient needs.
A proposed FDA study would look at the effects drug names have on perceptions of their effectiveness by consumers and doctors.
The FDA is taking public comment on new studies that will look at how drug risks are presented in direct-to-consumer print ads.
The FDA says it intends to launch an array of studies looking at drug marketing, it's accuracy, and effects on consumers and healthcare providers.
The FDA is preparing to conduct studies on whether doctors and consumers can detect deceptive drug advertising on websites.
A new study suggests that consumers tend to tune out long lists of drug side effects, causing them to miss important safety warnings.
The findings of a new study seem to back the FDA's belief that consumers will take more notice of drug risks in commercials if those lists are shorter and only…
A new study warns that testosterone advertising is leading men to seek prescriptions without getting properly tested for actual low testosterone levels.
A national pharmacist policy group has called for a ban on commercials and other direct-to-consumer advertisements, saying they promote drug overuse and are often misleading.
